Drugs / Cyclophosphamide
Drug research

Cyclophosphamide

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as Cytoxan®

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell TherapyNCT05714345Allogene TherapeuticsPhase 2Terminated2024-02-20Actual
Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AMLNCT07157514Actinium PharmaceuticalsPhase 2, Phase 3Not yet recruiting2029-02Estimated
Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic CancerNCT04390399IBRXPhase 2Active not recruiting2025-10-13Actual
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.NCT06072612BriaCell Therapeutics CorporationPhase 3Recruiting2027-12Estimated
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCLNCT06500273Allogene TherapeuticsPhase 2Recruiting2027-12Estimated

Regulatory dates and decisions

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.